infinity pharmaceuticals inc
(INFI:NASDAQ GS)
As of 8:10 PM 05/24/13 All times are local (Market data is delayed by at least 15 minutes).
Key Executives - infinity pharmaceuticals inc (INFI)
| Name | Board Relationships | Title | Age |
| Adelene Q. Perkins | 9 Relationships | Chairman of The Board, Chief Executive Officer and President | 52 |
| Lawrence E. Bloch M.D., J.D. | No Relationships | Chief Financial Officer, Chief Business Officer, Principal Accounting Officer, Executive Vice President, Treasurer and Secretary | 46 |
| Julian Adams Ph.D. | 39 Relationships | President of Research and Development | 57 |
| Pedro Santabárbara M.D., Ph.D. | 11 Relationships | Chief Medical Officer | 59 |
Board Members - infinity pharmaceuticals inc (INFI)
| Name | Board Relationships | Primary Company | Age |
| Adelene Q. Perkins | 9 Relationships | Infinity Pharmaceuticals, Inc. | 52 |
| Anthony B. Evnin Ph.D. | 187 Relationships | Venrock | 71 |
| Michael C. Venuti Ph.D. | 22 Relationships | Numerate, Inc. | 58 |
| Martin Babler | 20 Relationships | Talima Therapeutics, Inc. | 47 |
| Ian F. Smith CPA, ACA | 54 Relationships | Vertex Pharmaceuticals Incorporated | 46 |
Executive Committees* - infinity pharmaceuticals inc (INFI)
| Committee Name | Chairperson | Board Relationships | Members |
| Audit Committee | Ian F. Smith CPA, ACA | 54 Relationships | 3 Executives |
| Compensation Committee | Martin Babler | 20 Relationships | 3 Executives |
| Nominating Committee | Anthony B. Evnin Ph.D. | 187 Relationships | 3 Executives |
| Corporate Governance Committee | Anthony B. Evnin Ph.D. | 187 Relationships | 3 Executives |
*Data is at least as current as the most recent Definitive Proxy.
| Recently Viewed | |||
| INFI:US | $24.30 USD | -0.06 |  |
| Company | Last | Change |
| Array BioPharma Inc | $5.85 USD | +0.19 |
| Astex Pharmaceuticals | $5.36 USD | +0.24 |
| Exact Sciences Corp | $10.69 USD | +0.15 |
| Exelixis Inc | $4.74 USD | -0.03 |
| Keryx Biopharmaceuticals Inc | $8.03 USD | 0.00 |
| View Industry Companies | ||
Industry Analysis
INFI
Industry Average
| Valuation | INFI | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 52.8x |
|
| Price/Book | 4.0x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 40.8x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
Report Data Issue
To contact INFINITY PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Please enter your information in the following field(s):
Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
